Collaborations & Alliances

Armas, Micro Labs Collaborate for Generic Injectables Launch

Diphenhydramine Injection, the first multisource injectable product to be launched, will be brought to U.S. market in May

Armas Pharmaceuticals Inc. and Micro Labs USA, Inc. have formed a strategic collaboration to bring select multisource injectable products to the U.S. market. The first product, Diphenhydramine Injection 50mg/1mL, is slated to be launched in May. Additional product launches are set for the second quarter of 2019. The market size of these products total $100 million annually, according to IMS data.    “Armas Pharmaceuticals is excited to partner with Micro Labs as we look to expand our pro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters